Selective serotonin reuptake inhibitor discontinuation syndrome: A review

Advances in Therapy

Volumn 19, Issue 1, 2002, Pages 17-26

  Tamam, Lut ^a   Ozpoyraz, Nurgul ^a  

^a CUKUROVA UNIVERSITY FACULTY OF MEDICINE   (Turkey)

Author keywords

Adverse effects; Antidepressants; Discontinuation syndrome; Selective serotonin reuptake inhibitors

Indexed keywords

BENZODIAZEPINE DERIVATIVE; CITALOPRAM; DIPHENHYDRAMINE; FLUOXETINE; FLUVOXAMINE MALEATE; GINKGO BILOBA EXTRACT; MIRTAZAPINE; MONOAMINE OXIDASE INHIBITOR; NEFAZODONE; ONDANSETRON; PAROXETINE; SEROTONIN AGONIST; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

ANXIETY NEUROSIS; ARTICLE; CLINICAL TRIAL; DEPRESSION; DIAGNOSTIC APPROACH ROUTE; EATING DISORDER; HUMAN; LONG TERM CARE; META ANALYSIS; OBSESSION; PATIENT COMPLIANCE; PATIENT EDUCATION; SYMPTOMATOLOGY; WITHDRAWAL SYNDROME;

ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; HUMANS; SEROTONIN UPTAKE INHIBITORS; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 0036231396     PISSN: 0741238X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02850015     Document Type: Article

References (42)

1. The SSRI discontinuation syndrome
2. Withdrawal reactions with selective serotonin reuptake inhibitors as reported to the WHO system
3. A comparison of post-marketing safety of four selective re-uptake inhibitors including the investigation of symptoms occurring on withdrawal
4. The abrupt discontinuation of fluvoxamine in patients with panic disorder
5. Selective serotonin reuptake inhibitor discontinuation syndrome: Proposed diagnostic criteria
6. Abrupt and brief discontinuation of antidepressant treatment: Effects on cognitive function and psychomotor performance
7. Antidepressant discontinuation reactions
8. Antidepressant discontinuation: A review of the literature
9. Withdrawal symptoms after discontinuation of selective serotonin reuptake inhibitors
10. Selective serotonin reuptake inhibitor discontinuation syndrome: A randomized clinical trial
11. Discontinuation symptoms after treatment with serotonin reuptake inhibitors: A literature review
12. SSRI withdrawal syndrome
13. Mirtazapine withdrawal symptoms
14. Venlafaxine withdrawal reactions
15. Withdrawal symptoms associated with paroxetine discontinuation in a 9-year old boy
16. Withdrawal syndromes after paroxetine and sertraline discontinuation
17. Shock-like sensations after discontinuation of selective reuptake inhibitors
18. Paroxetine induced withdrawal effects
19. Nefazodone withdrawal symptoms
20. Withdrawal reactions after sertraline discontinuation
21. Extrapyramidal symptoms upon discontinuation of fluoxetine
22. Fluvoxamine withdrawal syndrome
23. Sertraline withdrawal in 2 brothers: A case report
24. Serotonin reuptake inhibitor withdrawal
25. Interruption of selective serotonin reuptake inhibitor treatment
26. Discontinuation syndromes with selective serotonin reuptake inhibitors. Are there clinically relevant differences?
27. Clinical experience with imipramine in the treatment of depression
28. The safety of fluoxetine: An update
29. Withdrawal symptoms after discontinuation of a citalopram treatment: A prospective study
30. Antidepressant withdrawal syndromes: Phenomenology and physiopathology
31. Serotonin reuptake inhibitor discontinuation syndrome: A hypothetical definition
32. Effects of third trimester fluoxetine exposure on the newborn
33. Suspected congenital sertraline dependence
34. Fluoxetine hydrochloride toxicity in neonates
35. Possible biological mechanisms of serotonin reuptake inhibitor discontinuation syndrome
36. Clinical management of antidepressant discontinuation
37. Antidepressant noncompliance as a factor in the discontinuation symptoms
38. Physician knowledge of antidepressant withdrawal effects: A survey
39. Physical symptoms associated with paroxetine withdrawal
40. Treatment of venlafaxine discontinuation symptoms with ondansetron